Synovus Financial Corp Sarepta Therapeutics, Inc. Transaction History

Synovus Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$127.12 - $172.34 $7,118 - $9,651	-56 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$93.0 - $171.7 $8,556 - $15,796	-92 Reduced 62.16%	56 $9,000
Q1 2020 Apr 24, 2020	BUY	$82.38 - $131.64 $7,578 - $12,110	92 Added 164.29%	148 $14,000
Q3 2018 Nov 01, 2018	BUY	$115.31 - $161.51 $6,457 - $9,044	56 New	56 $9,000

530

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Synovus Financial Corp with notifications on news.